Unlocking the Potential of ASCC1: A drug Target and Biomarker for the Treatment of Sleep Disorders

Target Name: ASCC1

NCBI ID: G51008

ASCC1

Unlocking the Potential of ASCC1: A drug Target and Biomarker for the Treatment of Sleep Disorders

Abstract:

Sleep disorders have become a significant public health issue due to their impact on overall quality of life, productivity, and daily functioning. Activating signal cointegrator 1 complex subunit 1 (ASCC1) has been identified as a potential drug target and biomarker for the treatment of sleep disorders. This article will review the current research on ASCC1, including its function, interactions with other molecules, and potential as a drug target.

Introduction:

Sleep disorders have a significant impact on an individual's quality of life, including reduced productivity, increased fatigue, and decreased overall functional performance. According to the National Sleep Foundation, approximately 50 million Americans have insomnia or sleep disorders, and these conditions can have significant economic and societal costs.

Recent studies have identified ASCC1, a complex subunit of the activating signal cointegrator 1 (ASC) gene, as a potential drug target and biomarker for the treatment of sleep disorders. ASCC1 has been shown to play a role in the regulation of sleep-wake cycles and has been linked to the development of various sleep disorders, including insomnia, obesity, and cardiovascular disease.

Function and Interactions:

ASCC1 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of gene expression and has been linked to the regulation of sleep-wake cycles. It is a component of the ASC complex, which is responsible for regulating the expression of genes involved in the sleep-wake cycle.

Recent studies have shown that ASCC1 can interact with several other molecules, including the protein hsp70, which is involved in the regulation of stress responses and has been shown to play a role in the pathophysiology of various sleep disorders. Additionally, ASCC1 has been shown to interact with the

Protein Name: Activating Signal Cointegrator 1 Complex Subunit 1

Functions: Plays a role in DNA damage repair as component of the ASCC complex (PubMed:29997253). Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation (PubMed:12077347). In cells responding to gastrin-activated paracrine signals, it is involved in the induction of SERPINB2 expression by gastrin. May also play a role in the development of neuromuscular junction

The "ASCC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASCC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets